Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis

European urology oncology - Tập 3 - Trang 183-197 - 2020
Gianluca Ingrosso1, Carlotta Becherini2, Andrea Lancia3, Saverio Caini4, Piet Ost5, Giulio Francolini2, Morten Høyer6, Marta Bottero1, Alberto Bossi7, Thomas Zilli8, Daniele Scartoni9, Lorenzo Livi2, Riccardo Santoni1, Irene Giacomelli9, Beatrice Detti2
1Department of Radiation Oncology, Tor Vergata General Hospital, University of Rome “Tor Vergata”, Rome, Italy
2Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy
3Radiation Oncology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
4Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Networking, Florence, Italy
5Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium
6Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
7Department of Radiotherapy, Gustave-Roussy Institute, Villejuif, France
8Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
9Proton Treatment Center, Azienda Provinciale per i Servizi Sanitari, Trento, Italy

Tài liệu tham khảo

Dearnaley, 2014, Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, Lancet Oncol, 15, 464, 10.1016/S1470-2045(14)70040-3 Beckendorf, 2011, 70Gy versus 80Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial, Int J Radiat Oncol Biol Phys, 80, 1056, 10.1016/j.ijrobp.2010.03.049 Roach, 2006, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference, Int J Radiat Oncol Biol Phys, 65, 965, 10.1016/j.ijrobp.2006.04.029 Vance, 2007, The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome, Int J Radiat Oncol Biol Phys, 67, 828, 10.1016/j.ijrobp.2006.09.027 Jones, 2011, Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic, Eur Urol, 60, 411, 10.1016/j.eururo.2011.01.007 Abd-Alazeez, 2015, Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images, Prostate Cancer Prostat Dis, 18, 128, 10.1038/pcan.2014.55 Evans, 2018, Prostate cancer-specific PET radiotracers: a review on the clinical utility in recurrent disease, Pract Radiat Oncol, 8, 28, 10.1016/j.prro.2017.07.011 Afshar-Oromieh, 2014, Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer, Eur J Nucl Med Mol Imaging, 41, 11, 10.1007/s00259-013-2525-5 Cooperberg, 2010, Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer, Cancer, 116, 5226, 10.1002/cncr.25456 Higgins, 2008 Moga, 2012 Nyaga, 2014, Metaprop: a Stata command to perform meta-analysis of binomial data, Arch Public Health, 72, 39, 10.1186/2049-3258-72-39 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 211539 Mbeutcha, 2017, Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy, Radiat Oncol, 12, 49, 10.1186/s13014-017-0789-9 Leroy, 2017, Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center, Radiat Oncol, 12, 95, 10.1186/s13014-017-0833-9 Janoray, 2016, Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: initial report, Cancer Radiother, 20, 275, 10.1016/j.canrad.2016.03.005 Rutenberg, 2016, Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy, Brachytherapy, 15, 722, 10.1016/j.brachy.2016.08.004 Zilli, 2016, Reirradiation of prostate cancer local failures after previous curative radiation therapy: long-term outcome and tolerance, Int J Radiat Oncol Biol Phys, 96, 318, 10.1016/j.ijrobp.2016.05.024 Fuller, 2015, High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment, Pract Radiat Oncol, 5, e615, 10.1016/j.prro.2015.04.009 Jereczek-Fossa, 2012, Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer, Int J Radiat Oncol Biol Phys, 82, 889, 10.1016/j.ijrobp.2010.11.031 Maenhout, 2017, Focal MRI-guided salvage high-dose-rate brachytherapy in patients with radiorecurrent prostate cancer, Technol Cancer Res Treat, 16, 1194, 10.1177/1533034617741797 Barbera, 2017, Salvage low dose rate brachytherapy for recurrent prostate cancer after external beam radiotherapy: results from a single institution with focus on toxicity and functional outcomes, Clin Med Insights Oncol, 11, 1, 10.1177/1179554917738765 Kollmeier, 2017, Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: a comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time, Brachytherapy, 16, 1091, 10.1016/j.brachy.2017.07.013 Baumann, 2017, Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation, Brachytherapy, 16, 291, 10.1016/j.brachy.2016.12.011 Wojcieszek, 2016, Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure, Radiother Oncol, 119, 405, 10.1016/j.radonc.2016.04.032 Rose, 2015, Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: association between dose and late toxicity, Brachytherapy, 14, 342, 10.1016/j.brachy.2015.01.002 Yamada, 2014, A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy, Brachytherapy, 13, 111, 10.1016/j.brachy.2013.11.005 Peters, 2014, Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life, Radiother Oncol, 112, 77, 10.1016/j.radonc.2014.06.013 Vargas, 2014, Salvage brachytherapy for recurrent prostate cancer, Brachytherapy, 13, 53, 10.1016/j.brachy.2013.10.012 Shimbo, 2013, Salvage I seed implantation for prostate cancer with postradiation local recurrence, Urol Int, 90, 294, 10.1159/000346322 Lahmer, 2013, Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy, Strahlenther Onkol, 189, 668, 10.1007/s00066-013-0373-7 Chen, 2013, Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes, Int J Radiat Oncol Biol Phys, 86, 324, 10.1016/j.ijrobp.2013.01.027 Jo, 2012, Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy—preliminary results, BJU Int, 109, 835, 10.1111/j.1464-410X.2011.10519.x Burri, 2010, Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer, Int J Radiat Oncol Biol Phys, 77, 1338, 10.1016/j.ijrobp.2009.06.061 Moman, 2010, Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy, Brachytherapy, 9, 119, 10.1016/j.brachy.2009.06.007 Aaronson, 2009, Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy, BJU Int, 104, 600, 10.1111/j.1464-410X.2009.08445.x Gawkowska-Suwinska, 2009, Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy, J Contemp Brachyther, 1, 211 Lee, 2008, Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy, Brachytherapy, 7, 17, 10.1016/j.brachy.2007.11.002 Nguyen, 2007, Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study, Cancer, 110, 1485, 10.1002/cncr.22934 Lee, 2007, Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience, Int J Radiat Oncol Biol Phys, 67, 1106, 10.1016/j.ijrobp.2006.10.012 Koutrouvelis, 2003, Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant, Technol Cancer Res Treat, 2, 339, 10.1177/153303460300200409 Crouzet, 2017, Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: multi-institutional analysis of 418 patients, BJU Int, 119, 896, 10.1111/bju.13766 Dason, 2018, High-intensity focused ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response, Int Braz J Urol, 44, 248, 10.1590/s1677-5538.ibju.2017.0025 Jones, 2018, High intensity focused ultrasound for radiorecurrent prostate cancer: a North American clinical trial, J Urol, 199, 133, 10.1016/j.juro.2017.06.078 Kanthabalan, 2017, Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer, BJU Int, 120, 246, 10.1111/bju.13831 Siddiqui, 2017, Pathological, oncologic and functional outcomes of a prospective registry of salvage high intensity focused ultrasound ablation for radiorecurrent prostate cancer, J Urol, 197, 97, 10.1016/j.juro.2016.06.092 Shah, 2016, PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure, Prostate Cancer Prostat Dis, 19, 311, 10.1038/pcan.2016.23 Song, 2014, High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapy, Korean J Urol, 55, 91, 10.4111/kju.2014.55.2.91 Yutkin, 2014, Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy, Urology, 84, 1157, 10.1016/j.urology.2014.06.054 Ahmed, 2012, Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy, Cancer, 118, 3071, 10.1002/cncr.26631 Uchida, 2011, High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy, BJU Int, 107, 378, 10.1111/j.1464-410X.2010.09518.x Berge, 2011, Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer, Int J Urol, 18, 646 Murat, 2009, Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer, Eur Urol, 55, 640, 10.1016/j.eururo.2008.04.091 Gelet, 2004, Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography, Urology, 63, 625, 10.1016/j.urology.2004.01.002 Kongnyuy, 2017, Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients, Int J Hyperthermia, 33, 810 Ginsburg, 2017, Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation, Prostate, 77, 1446, 10.1002/pros.23406 Kovac, 2016, Five-year biochemical progression-free survival following salvage whole-gland prostate cryoablation: defining success with nadir prostate-specific antigen, J Endourol, 30, 624, 10.1089/end.2015.0719 Lian, 2016, Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy, Int Urol Nephrol, 48, 1461, 10.1007/s11255-016-1339-3 Li, 2015, Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the Cryo On-Line Data registry, Prostate, 75, 1, 10.1002/pros.22881 Ahmad, 2013, Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer, PLoS One, 8, e69243, 10.1371/journal.pone.0069243 de Castro Abreu, 2013, Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy, BJU Int, 112, 298, 10.1111/bju.12151 Spiess, 2013, Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry, World J Urol, 31, 1321, 10.1007/s00345-012-0982-2 Philippou, 2012, Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience, Urol Int, 88, 137, 10.1159/000332220 Williams, 2011, Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer, Eur Urol, 60, 405, 10.1016/j.eururo.2010.12.012 Spiess, 2010, A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer, BJU Int, 106, 194, 10.1111/j.1464-410X.2009.09078.x Pisters, 2009, Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy, J Urol, 182, 517, 10.1016/j.juro.2009.04.006 Eisenberg, 2008, Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure, Urology, 72, 1315, 10.1016/j.urology.2008.03.040 Ismail, 2007, Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients, BJU Int, 100, 760, 10.1111/j.1464-410X.2007.07045.x Ng, 2007, Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome, J Urol, 178, 1253, 10.1016/j.juro.2007.05.137 Spiess, 2006, Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy, Cancer, 107, 275, 10.1002/cncr.21979 Donnelly, 2005, Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy, Prostate Cancer Prostat Dis, 8, 235, 10.1038/sj.pcan.4500811 Bahn, 2003, Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up, Clin Prostate Cancer, 2, 111, 10.3816/CGC.2003.n.018 Izawa, 2003, Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy, Int J Radiat Oncol Biol Phys, 56, 468, 10.1016/S0360-3016(02)04574-1 Ghafar, 2001, Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience, J Urol, 166, 1333, 10.1016/S0022-5347(05)65763-1 Chin, 2001, Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications, J Urol, 165, 1937, 10.1016/S0022-5347(05)66246-5 de la Taille, 2000, Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience, Urology, 55, 79, 10.1016/S0090-4295(99)00390-8 Chade, 2012, Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature, Eur Urol, 61, 961, 10.1016/j.eururo.2012.01.022 Wu, 2013, Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy, Clin Oncol, 25, 252, 10.1016/j.clon.2012.11.010